Roberts E C, Hobson C H, Anderson R P, Chadwick V S
Wellcome Medical Research Institute, University of Otago Medical School, Dunedin, New Zealand.
J Gastroenterol Hepatol. 1990 Jan-Feb;5(1):38-43. doi: 10.1111/j.1440-1746.1990.tb01766.x.
Bacterial chemotactic peptides (F-met-oligopeptides) are secreted by several species of commensal enteric bacteria and can be assayed by bioassay techniques in human colonic luminal fluid. We have previously demonstrated intestinal absorption and enterohepatic circulation of radiolabelled F-met peptides introduced into rat colon, and an eightfold increase in absorption and biliary excretion in rats with experimental colitis. This paper describes the application of a radio-immunoassay to measurements of formyl oligopeptides in human faecal dialysates, colonic and systemic venous blood and bile. All samples were fractionated by reverse-phase high performance liquid chromatography (HPLC) prior to assay. Immunoreactivity was found in faecal dialysates (5-700 nmol/L F-met-leu-phe equivalents) and bile samples (3-150 nmol/L) from normal subjects. After HPLC fractionation, up to five distinct peaks of immunoreactivity were identified. One of these co-chromatographed with authentic F-met-leu-phe; the others probably represented either closely related peptides or peptides of different chain lengths originating from the same F-met-leu-phe precursor protein. Colonic venous blood from two patients with ulcerative colitis contained immunoreactive peptide (10-30 nmol/L) and substantial immunoreactivity was found in ileostomy fluid and bile from two patients with primary sclerosing cholangitis. These results suggest the presence of an enterohepatic circulation of bacterial F-met oligopeptides in man and provide a basis for studies of the role of such pro-inflammatory peptides in patients with inflammatory bowel disease and associated hepatobiliary disorders.
细菌趋化肽(F-甲硫氨酸寡肽)由几种共生肠道细菌分泌,可通过生物测定技术在人结肠腔液中进行检测。我们之前已证明,将放射性标记的F-甲硫氨酸肽引入大鼠结肠后会发生肠道吸收和肠肝循环,并且在实验性结肠炎大鼠中吸收和胆汁排泄增加了八倍。本文描述了放射免疫测定法在测量人粪便透析液、结肠和全身静脉血以及胆汁中的甲酰化寡肽方面的应用。所有样品在测定前均通过反相高效液相色谱(HPLC)进行分离。在正常受试者的粪便透析液(5 - 700 nmol/L F-甲硫氨酸-亮氨酸-苯丙氨酸当量)和胆汁样品(3 - 150 nmol/L)中发现了免疫反应性。经过HPLC分离后,鉴定出多达五个不同的免疫反应性峰。其中一个与 authentic F-甲硫氨酸-亮氨酸-苯丙氨酸共色谱;其他可能代表密切相关的肽或源自同一F-甲硫氨酸-亮氨酸-苯丙氨酸前体蛋白的不同链长的肽。两名溃疡性结肠炎患者的结肠静脉血中含有免疫反应性肽(10 - 30 nmol/L),并且在两名原发性硬化性胆管炎患者的回肠造口液和胆汁中发现了大量免疫反应性。这些结果表明人类中存在细菌F-甲硫氨酸寡肽的肠肝循环,并为研究此类促炎肽在炎症性肠病和相关肝胆疾病患者中的作用提供了基础。